Skip to main content

Advertisement

Log in

Ligand Binding Assays in the 21st Century Laboratory—A Call for Change

  • Editorial
  • Theme: Ligand Binding Assays in the 21st Century Laboratory
  • Published:
The AAPS Journal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22(2):151–85.

    Article  PubMed  Google Scholar 

  2. Adams CP, Brantner VV. Spending on new drug development. Heal Econ. 2010;19(2):130–41.

    Article  Google Scholar 

  3. O’ Hara DM, Theobald V, Egan A, Usansky J, Krishna M, TerWee J, Maia M, Spriggs F, Kenney J, Safavi A, Keefe J. Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents. AAPS J. 2012. doi:10.1208/s12248-012-9334-9.

  4. Spriggs FP, Zhandong DZ, Safavi A, Jani D, Dontha N, Kant A, Ly J, Brilando L, Osterlund K, Rouleau N, Fischer S, Boissonneault M, Ray CA. Ligand binding assays in the 21st century laboratory: platforms. AAPS J. 2012;14(1):113–8.

    Article  PubMed  Google Scholar 

  5. Ahene AB, Morrow C, Rusnak D, Spitz S, Usansky J, Pils H, Civoli F, Pandya K, Sue B, Leach D, Derent J. Ligand binding assays in the 21st century: automation. AAPS J. 2012;14(1):142–53.

    Article  PubMed  Google Scholar 

  6. Leung SS, Usansky J, Lynde R, Thway T, Hendricks R, Rusnak D. Ligand-binding assays in the 21st century laboratory: recommendations for an automated data interchange process. AAPS J. 2012;14(1):105–12.

    Article  PubMed  Google Scholar 

  7. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005;1(1):55–66.

    Article  PubMed  Google Scholar 

  8. Jarvis LM. Chem Eng News. 2010;88(23):14–5.

    Google Scholar 

  9. The Writing Group for the WHI Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results of the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Article  Google Scholar 

  10. Freedom CAR and Fuel Partnership 2010 Highlights of Technical Accomplishments. (2010). Retrieved January 5, 2012, from http://www1.eere.energy.gov/vehiclesandfuels/pdfs/program/2010_fcfp_accomplishments_rpt.pdf

Download references

Acknowledgments

The authors would like to acknowledge the significant contributions made by AAPS staff and all of the many volunteers. We would also like to recognize the leadership provided by the members of the action program committee and the sub-team leaders: Jean Lee, Valerie Quarmby, Marian Kelley, Franklin Spriggs, Denise O’ Hara, and Sheldon Leung. We would also like to recognize the many authors that spent countless hours discussing, debating, and honing the messages found in this theme issue.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chad A. Ray.

Additional information

Guest Editors: William Nowatzke, Ago Ahene, and Chad Ray

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ray, C.A., Ahene, A.B. Ligand Binding Assays in the 21st Century Laboratory—A Call for Change. AAPS J 14, 377–379 (2012). https://doi.org/10.1208/s12248-012-9351-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-012-9351-8

Navigation